These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 8746593)
1. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Jager J; Langendijk H; Pannebakker M; Rijken J; de Jong J Radiother Oncol; 1995 Dec; 37(3):237-40. PubMed ID: 8746593 [TBL] [Abstract][Full Text] [Related]
2. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center. Bhatt L; Tirmazy S; Sothi S Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484 [TBL] [Abstract][Full Text] [Related]
3. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases. Ghosh S; Sau S; Mitra S; Manna A; Ghosh K J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668 [TBL] [Abstract][Full Text] [Related]
4. Palliation in esophageal cancer with a single session of intraluminal irradiation. Jager JJ; Pannebakker M; Rijken J; de Vos J; Vismans FJ Radiother Oncol; 1992 Oct; 25(2):134-6. PubMed ID: 1279749 [TBL] [Abstract][Full Text] [Related]
5. Intraluminal high dose rate brachytherapy of tumorous esophageal stenoses. Dvorak J; Petera J; Kabelac K; Melichar B; Voboril R; Filip S; Vosmik M; Hulek P Hepatogastroenterology; 2006; 53(71):702-4. PubMed ID: 17086872 [TBL] [Abstract][Full Text] [Related]
6. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy. Sharma V; Mahantshetty U; Dinshaw KA; Deshpande R; Sharma S Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):310-5. PubMed ID: 11872275 [TBL] [Abstract][Full Text] [Related]
7. Combination of laser treatment and intraluminal radiotherapy for malignant dysphagia. Shmueli E; Srivastava E; Dawes PJ; Clague M; Matthewson K; Record CO Gut; 1996 Jun; 38(6):803-5. PubMed ID: 8984013 [TBL] [Abstract][Full Text] [Related]
8. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150 [TBL] [Abstract][Full Text] [Related]
9. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study. Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950 [TBL] [Abstract][Full Text] [Related]
10. High dose rate brachytherapy for the palliation of malignant dysphagia. Homs MY; Eijkenboom WM; Coen VL; Haringsma J; van Blankenstein M; Kuipers EJ; Siersema PD Radiother Oncol; 2003 Mar; 66(3):327-32. PubMed ID: 12742273 [TBL] [Abstract][Full Text] [Related]
11. Palliation of malignant dysphagia by laser therapy. Savage AP; Baigrie RJ; Cobb RA; Barr H; Kettlewell MG Dis Esophagus; 1997 Oct; 10(4):243-6. PubMed ID: 9455650 [TBL] [Abstract][Full Text] [Related]
12. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Sur RK; Donde B; Levin VC; Mannell A Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834 [TBL] [Abstract][Full Text] [Related]
13. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Taal BG; Aleman BM; Koning CC; Boot H Br J Cancer; 1996 Nov; 74(9):1452-7. PubMed ID: 8912544 [TBL] [Abstract][Full Text] [Related]
14. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207). Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897 [TBL] [Abstract][Full Text] [Related]
15. Intraluminal brachytherapy in the treatment of oesophageal cancers--some preliminary results. Wee JT; Theobald DR; Chua EJ Ann Acad Med Singap; 1994 Mar; 23(2):226-30. PubMed ID: 7521615 [TBL] [Abstract][Full Text] [Related]
16. High dose rate brachytherapy for superficial cancer of the esophagus. Maingon P; d'Hombres A; Truc G; Barillot I; Michiels C; Bedenne L; Horiot JC Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):71-6. PubMed ID: 10656375 [TBL] [Abstract][Full Text] [Related]
17. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer. Homs MY; Steyerberg EW; Eijkenboom WM; Siersema PD; Brachytherapy; 2006; 5(1):41-8. PubMed ID: 16563996 [TBL] [Abstract][Full Text] [Related]
18. Laser versus laser plus afterloading with iridium-192 in the palliative treatment of malignant stenosis of the esophagus: a prospective, randomized, and controlled study. Sander R; Hagenmueller F; Sander C; Riess G; Classen M Gastrointest Endosc; 1991; 37(4):433-40. PubMed ID: 1717341 [TBL] [Abstract][Full Text] [Related]
19. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study. Spencer GM; Thorpe SM; Blackman GM; Solano J; Tobias JS; Lovat LB; Bown SG Gut; 2002 Feb; 50(2):224-7. PubMed ID: 11788564 [TBL] [Abstract][Full Text] [Related]
20. Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma. Greene FL; Boulware RJ; Bianco J Surg Laparosc Endosc; 1995 Dec; 5(6):425-30. PubMed ID: 8611986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]